Dr. Muhubiri Kabuyaya holds a degree in Medicine from the "Universite Evangelique en Afrique (UEA)"/Demogratic Republic of Congo and a PhD in Public Health from the University of KwaZulu-Natal. He is a passionate medical researcher with a special interest on Tropical Infectious Diseases. Dr. Kabuyaya's main focus is on schistosomiasis. He has investigated the risk factors of schistosomiasis transmission and the efficacy of the repeated standard dose of praziquantel against Schistosoma haematobium among school-going children in Ingwavuma area of uMkhanyakude district in KwaZulu-Natal, South Africa. He is currently working on the efficacy of praziquantel given at 60 mg/kg and the population genetics of Schistosoma haematobium post treatment.